Document Detail


Strict Stereocontrol by 2,4-O-Di-tert-butylsilylene Group on β-Glucuronylations.
MedLine Citation:
PMID:  22471275     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Strict β-controlled glucuronylations without classical neighboring-group participation were achieved by the assistance of a 2,4-O-di-tert-butylsilylene group. Comparison of activation conditions and conformational analysis indicated that the strict β-selectivity was achieved by steric hindrance of the 2,4-O-di-tert-butylsilylene group and not by complex glycosyl intermediates.
Authors:
Takayuki Furukawa; Hiroshi Hinou; Shin-Ichiro Nishimura
Related Documents :
22754565 - Laparoscopic partial nephrectomy: is it worth still performing the retroperitoneal route?
22451455 - Endovenous laser ablation with and without high ligation compared with high ligation an...
22752925 - Quantitative analysis of isolation area and rhythm outcome in patients with paroxysmal ...
2676405 - Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of ther...
626115 - Embolism in sinoatrial disease.
17274045 - Pediatric hospitalist comanagement of spinal fusion surgery patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-3
Journal Detail:
Title:  Organic letters     Volume:  -     ISSN:  1523-7052     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100890393     Medline TA:  Org Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Graduate School of Life Science and Frontier Research Center for Post-Genome Science and Technology, Hokkaido University, N21, W11, Kita-ku, Sapporo 001-0021, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neona...
Next Document:  Acute Inpatient Presentation of Kwashiorkor: Not Just a Diagnosis of the Developing World.